Thermo and NanoPin Announce Collaboration
Thermo Fisher Scientific has announced a collaboration with NanoPin Technologies, Inc. to improve blood-based infectious disease detection technology through the development of highly sensitive LC–MS‑based workflows.
Thermo Fisher Scientific (Waltham, Massachusetts, USA) has announced a collaboration with NanoPin Technologies, Inc. (New Orleans, Louisiana, USA) to improve blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography–mass spectrometry (LC–MS)âbased workflows.
The companies will combine Thermo Fisher’s LC–MS technology with NanoPin’s diagnostic platform to detect disease-related antigens directly from patient blood samples, which will lead to the development of sensitive clinical assays for infectious disease. The overall aim is to reduce diagnosis times and improve the determination of infection stage, as well as monitor patient response to prescribed treatments.
For more information please visit: www.thermofisher.com
Influence of Concentration in Conventional GPC/SEC and Advanced Detection GPC/SEC
March 21st 2025Sample concentration is a parameter that can influence the quality of gel permeation chromatography/size-exclusion chromatography (GPC/SEC) separations and the obtained results. Understanding this influence can help to support the development of reliable GPC/SEC methods.
Multi-Step Preparative LC–MS Workflow for Peptide Purification
March 21st 2025This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid chromatography–mass spectrometry (LC–MS). The process involves optimizing separation conditions, scaling-up, fractionating, and confirming purity and recovery, using a single LC–MS system. High purity and recovery rates for synthetic peptides such as parathormone (PTH) are achieved. The method allows efficient purification and accurate confirmation of peptide synthesis and is suitable for handling complex preparative purification tasks.
